Releasing a diagnostic or prognostic test shouldn't be easy. I've worked in biotech my entire career and it's just too easy to screw up. There are already far too many shortcuts taken in CLIA labs and the LDT space.
> too many shortcuts taken in CLIA labs and the LDT space.
jesus fuck, this is NOT what I need to hear as we push our salvage therapy companion biomarker into a 160 patient trial.
then again I work in pediatrics these days and nobody ever made any money in peds. So I guess there's that. People expect their 99-year-old grandpa to die of prostate cancer (or apnea, or constipation, or...). It's rather a more unpleasant shock when your 3-year-old does the dying.
Won't make anyone rich but maybe it'll relieve a little suffering in the world. I guess I'd best be OK with that.
